The Enterprise Value as of December 2025 (TTM) for Carna Biosciences, Inc. (CBIXF) is 6.55B

According to Carna Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.55B. This represents a change of 54.74% compared to the average of 4.23B of the last 4 quarters.

Carna Biosciences, Inc. (CBIXF) Historical Enterprise Value (quarterly & annually)

How has CBIXF Enterprise Value performed in the past?

The mean historical Enterprise Value of Carna Biosciences, Inc. over the last ten years is 11.17B. The current 6.55B Enterprise Value has changed 5.77% with respect to the historical average. Over the past ten years (40 quarters), CBIXF's Enterprise Value was at its highest in in the March 2016 quarter at 29.69B. The Enterprise Value was at its lowest in in the December 2024 quarter at 3.65B.

Carna Biosciences, Inc. (CBIXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Carna Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Carna Biosciences, Inc. (CBIXF) Average Enterprise Value

How has CBIXF Enterprise Value performed in the past?

The current Enterprise Value of Carna Biosciences, Inc. (CBIXF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Carna Biosciences, Inc. (CBIXF) Enterprise Value vs. Peers

How is CBIXF’s Enterprise Value compared to its peers?

Carna Biosciences, Inc.’s Enterprise Value is greater than Adocia S.A. (124.33M), greater than Recce Pharmaceuticals Ltd (176.72M), less than AnGes, Inc. (19.01B), greater than Broncus Holding Corporation (130.62M), less than Prescient Therapeutics Limited (0), greater than NanoRepro AG (9.19M), greater than Faron Pharmaceuticals Oy (218.40M), less than Ascentage Pharma Group International (19.33B), greater than Eupraxia Pharmaceuticals Inc. (203.97M), greater than EKF Diagnostics Holdings plc (96.33M),

Build a custom stock screener for Carna Biosciences, Inc. (CBIXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carna Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carna Biosciences, Inc. (CBIXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carna Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.